Radiopharm Theranostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RADX and other ETFs, options, and stocks.About RADX
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.
CEORiccardo Canevari
CEORiccardo Canevari
Employees—
Employees—
HeadquartersCarlton, Victoria (VIC)
HeadquartersCarlton, Victoria (VIC)
Founded2021
Founded2021
Employees—
Employees—
RADX Key Statistics
Market cap48.91M
Market cap48.91M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume19.10K
Average volume19.10K
High today$26.96
High today$26.96
Low today$5.01
Low today$5.01
Open price$4.07
Open price$4.07
Volume5.12M
Volume5.12M
52 Week high$26.96
52 Week high$26.96
52 Week low$3.50
52 Week low$3.50
Stock Snapshot
The current Radiopharm Theranostics(RADX) stock price is $16.70, with a market capitalization of 48.91M. The stock trades at a price-to-earnings (P/E) ratio of -1.23.
On 2025-12-15, Radiopharm Theranostics(RADX) stock traded between a low of $5.01 and a high of $26.96. Shares are currently priced at $16.70, which is +233.3% above the low and -38.1% below the high.
The Radiopharm Theranostics(RADX)'s current trading volume is 5.12M, compared to an average daily volume of 19.1K.
In the last year, Radiopharm Theranostics(RADX) shares hit a 52-week high of $26.96 and a 52-week low of $3.50.
In the last year, Radiopharm Theranostics(RADX) shares hit a 52-week high of $26.96 and a 52-week low of $3.50.